Discovery of AM-6494: A Potent and Orally Efficacious beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitor with in Vivo Selectivity over BACE2.
Pettus, L.H., Bourbeau, M.P., Bradley, J., Bartberger, M.D., Chen, K., Hickman, D., Johnson, M., Liu, Q., Manning, J.R., Nanez, A., Siegmund, A.C., Wen, P.H., Whittington, D.A., Allen, J.R., Wood, S.(2020) J Med Chem 63: 2263-2281
- PubMed: 31589043 
- DOI: 10.1021/acs.jmedchem.9b01034
- Primary Citation of Related Structures:  
6PZ4 - PubMed Abstract: 
β-Site amyloid precursor protein cleaving enzyme 1 (BACE1) is an aspartyl protease that plays a key role in the production of amyloid β (Aβ) in the brain and has been extensively pursued as a target for the treatment of Alzheimer's disease (AD). BACE2, an aspartyl protease that is structurally related to BACE1, has been recently reported to be involved in melanosome maturation and pigmentation ...